LEVO
Live / Allowed — Notice of allowance issued (as of 24 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 04 Apr 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99121153
- Mark type
- Stylized text
- Filed
- 04 Apr 2025
- Published for opposition
- 30 Dec 2025
- Attorney of record
- Carissa L. Weiss
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of Prader-Willi syndrome (PWS) and related disorders; Pharmaceutical preparations for the treatment of neurodevelopmental and metabolic disorders
Owner
- Acadia Pharmaceuticals, Inc., San Diego, CA, US
- Acadia Pharmaceuticals, Inc., San Diego, CA, US
Prior registrations
Prosecution history
- 24 Feb 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Dec 2025 — PUBLISHED FOR OPPOSITION
- 24 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 12 Aug 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 12 Aug 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 30 May 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 30 May 2025 — NON-FINAL ACTION E-MAILED
- 30 May 2025 — NON-FINAL ACTION WRITTEN
- 28 May 2025 — ASSIGNED TO EXAMINER
- 04 Apr 2025 — APPLICATION FILING RECEIPT MAILED